Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

The ruling requires all trials across the EU to be filed through the European Medicines Agency’s digital filing system.

Experts at the 2025 Clinical Trial Supply Europe will explore supply chain challenges and the impact of AI on trials.

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive ...

Approval from EMA to expand the Phase III trial FLAMINGO-01 into Europe enhances the company's research capabilities and potential market reach. The activation of approximately 110-115 clinical ...

"EMA approves addition of sites to Greenwich LifeSciences’ breast cancer trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this ...

High-quality evidence for the treatment of very rare diseases: IQWiG is involved in the EU project RealiseD Developing clinical trials to provide good evidence for very rare diseases, so that ...

Greenwich LifeSciences (GLSI), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is ...

A clinical trial of tecovirimat (TPOXX®, SIGA ... CHMP refers to the Committee for Medicinal Products for Human Use, which is the European Medicines Agency's (EMA) committee responsible for human ...